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doi:10.1016/j.ejvs.2008.07.007Abstract Objective: To quantify the risk of DVT in arterial surgery, and to assess the need for
prophylaxis.
Methods: A search was carried out through Medline, Embase and Cochrane databases to iden-
tify published studies on DVT in arterial surgery. To quantify the risk of DVT both randomised
and prospective non-randomised studies were included for analysis. However, to assess the
need for prophylaxis only randomised controlled trials were considered.
Results: Twenty three prospective studies that evaluated DVT in arterial surgery were identi-
fied. Ten reported data about DVT in aortic surgery, seven studies evaluated DVT in general
vascular surgery, three studied DVT in infra-inguinal vascular surgery and three studied DVT
incidence in patients after limb amputations.
Conclusion: There is a wide variation in the reported incidence of DVT in arterial surgery (2%e
24%). This is mostly due to the diversity of screening methods used and the inclusion or exclu-
sion of below knee DVT.
There is insufficient evidence to make a valid conclusion regarding the routine use of anti-
coagulants prophylaxis in arterial surgery. However, until such evidence becomes available,
DVT prophylaxis in patients undergoing arterial surgery will continue to be guided by evidence
gained from studies of general surgical patients.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.1282 804642; fax: þ44 1282
.com (H. Al-khaffaf).
ty for Vascular Surgery. PublisheIntroduction
In contrast to general and orthopaedic surgery the inci-
dence of DVT following arterial surgery has attracted very
little attention. Despite being the surgical specialty that
mostly deals with vessels, clots, and thrombo-embolic
phenomena, vascular surgery seems to have no guidelinesd by Elsevier Ltd. All rights reserved.
566 M. Bani-Hani et al.when it comes to post-operative DVT prophylaxis. NICE
guidelines highlight the lack of specific evidence in this
field (particularly for patients not receiving thrombopro-
phylaxis) and rely on conclusions derived from general
surgery without taking into account the characteristics of
vascular patients or the surgical procedure itself.1
On the other hand, and despite the strong recommen-
dation in high risk group of vascular patients, the American
College of chest physicians (ACCP) recommendation comes
with concerns regarding the methodological quality (grade
1Cþ). While the evidence for the low risk group was
essentially weak (grade 2B).2
The fact that most vascular patients are generally older,
with limited mobility, and higher rate of co-morbidities
puts this group of patients at a higher risk of developing
deep venous thrombosis. However, the anecdotal experi-
ence of most vascular surgeons suggests that practically
this is not the case.3 This has been generally attributed to
the essential step of intra-operative heparin used in nearly
all arterial procedures, which is thought to be the peak
time for most clot formation.4,5 On the other hand, the fact
that bleeding complications are far more serious in this
particular group of patients6 and most of them are already
on antiplatelets (aspirin and or clopidogrel) can make some
surgeons rather reluctant to use additional anti-coagulants
in these circumstances. In a recent review published in the
Cochrane library,7 we demonstrated the lack of quality
evidence for DVT prophylaxis in aortic surgery.
Methods
A search was performed through Medline, Embase, and
Cochrane databases for published studies in the English
language that have evaluated Deep Venous Thrombosis in
arterial surgery. We used the keywords ‘‘DVT’’, ‘‘ Deep vein
thrombosis’’, Pulmonary embolism’’ ‘‘Arterial surgery’’,
‘‘vascular surgery’’ ’’Aortic surgery’’, ‘‘Infra-inguinal
revascularisation’’ and ‘‘amputations’’. Full texts of all
relevant articles were obtained and analysed for the pre-
determined parameters. We also searched for additional
trials through reference lists of retrieved studies.
Toquantify the risk ofDVTboth randomisedandprospective
non-randomised studies reporting data of DVT incidence in
arterial operations (regardless of the prophylactic method)
were included for analysis. However, to assess the need for
prophylaxis and safety of intervention, only randomised
controlled trials (RCTs) comparing anticoagulants (with or
without mechanical methods) to controls were included.
All studies were analysed for the incidence of DVT,
procedures performed, methods of screening for DVT,
prophylactic method used, incidence of pulmonary embo-
lism, mortality, difficulties encountered and recommenda-
tions made by the authors.
Results
Twenty three prospective studies that evaluated DVT in
arterial surgery were identified (see Table 1). For the
purpose of this review they were classified according to the
type of intervention into four groups: Aortic surgery,
General arterial surgery, peripheral non-aorticreconstructive surgery, and amputations. Carotid cases
were only included as a part of general vascular studies8,9
and as expected, our search failed to identify any study
that evaluated DVT in carotid surgery alone.
Ten studies reported data about DVT in aortic surgery, of
which three were randomised controlled trials, and seven
prospective but non-randomised studies. Seven studies eval-
uated DVT in vascular procedures in general (including some
aortic cases); of which four were randomised. Unfortunately
all the studies that investigated infra-inguinal revascularisa-
tion and amputations were non-randomised. Naturally, there
was an element of overlap between Aortic and general
vascular cases, and definite separation between the two
groups was impossible in some studies.
In the aortic-only group only three studies were rando-
mised (RCTs) amongwhich twoonlycomparedanti-coagulants
to control. Killewich et al.10 reported an incidence of 2% in
both groups, while Belch et al.6 estimated a DVT incidence of
24% in the no-treatment group. However, the latter studywas
not completed because of significant hemorrhagic
complications.
All the other seven non-randomized aortic studies
(nZ 407) did not adopt any anticoagulant regimen and
reported an incidence that ranged between 0e20.5%
averaging 9.2%. Notably, this incidence comes down to 2.6%
if calf DVT is excluded.
Only a single study looked at the risk of DVT in EVAR11
and reported a DVT incidence of 6% only.
In the general arterial surgery group seven studies were
identified; four RCTs (nZ 660) and three prospective non-
randomized studies (nZ 114). In RCT group only Spebar
et al. study9 compared anticoagulants (heparin) to control
and reported an incidence of 12.5% and 10.5% respectively,
with no significant difference between the two. However
the number of cases included was very small (nZ 43).
In the peripheral non-aortic group three prospective
non-randomised studies were identified and none of them
used heparin prophylaxis with a DVT incidence that varied
between 2.8% and 8%.
In the amputations group no RCTs were identified and only
two prospective studies were considered. These reported
a variable incidence of DVT between (0e12.5percent). Addi-
tional 21 cases were studied as a part of general vascular
operations in Fletcher12 study with DVT incidence of 14.3%.
Discussion
There was a large discrepancy in the reported incidence of
DVT. Apart from the variations in the settings, sample
characteristics and experimental protocols the main
differences can be attributed to two main reasons. Firstly,
the diversity of screening methods used and their sensi-
tivity and specificity. Secondly, the controversial issue of
below knee DVT, which is highly emphasised in some studies
and totally ignored by others.
DVT in aortic surgery
Among the three RCTs in this group two only compared anti-
coagulants to control. Interestingly both studies recom-
mended no anticoagulation for different reasons.
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criteria was Killewich et al.10 study on a hundred patients’
sample, half of whom were given aggressive DVT prophy-
laxis in the form of a combination of low-dose, unfractio-
nated heparin sodium 5000U subcutaneously every
12 hours, and calf-length IMC device intraoperatively and
continued postoperatively for 7 days or until the patient
was fully ambulatory. The other half had no prophylaxis at
all. It reported a very low incidence of DVT of 2% in both
control and intervention group using colour flow duplex
scan at one day and four weeks post operatively. Notably,
below knee DVT was not addressed and considered insig-
nificant. Although only one patient in each group developed
DVT, the control case propagated into a non-fatal PE. The
authors attributed this to higher co-morbidity, and longer
hospitalisation period in that particular patient. Conse-
quently, the authors recommended only selective prophy-
laxis in high-risk groups but not routine anticoagulation.
On the other hand, Belch et al. study reported the
highest DVT incidence in a randomised trial (24%). They also
reported the highest rate of hemorrhagic complications in
a randomised trial which led to early termination of the
study just after recruiting one third of the intended 150
cases. Significant bleeding complications in this trial
included one case of major GI bleed and four other cases of
retroperitoneal haemorrhage that led to two deaths.
Consequently, the results did not reach statistical signifi-
cance. However, the authors calculated the risk of DVT to
be 24% in the control group. Interestingly, Belch et al.
included all below knee DVT cases in their count although
only one case extended above the calf which can make the
incidence of ‘‘significant ’’ DVT 2% if Killewich definition
was used!
Nevertheless, Belch et al. recommended DVT prophy-
laxis in aortic surgery with avoidance of anticoagulants to
reduce the risk of major post-operative bleeding. Notably,
similar high rate of bleeding complications have not been
reported in any other study despite using similar and even
higher heparin dose regiment.
The third RCT by Speziale et al.13 on a 92 patients
compared UFH to LMWH and not to no-treatment control
and reported a DVT incidence of 8.6% and 6.5% respectively
detected by FUT and Doppler ultrasound.
The relatively higher incidence of DVT in the no-
prophylaxis group comes mainly from two prospective non-
randomised studies with DVT incidences, 20%,14 and 18%15
while all the other studies reported an incidence between
0%e7.7percent.
Angelides et al. reported a high incidence of DVT (20%)14
on a sample of 88 patients. Cases were diagnosed by
Fibrinogen uptake test only (which is known to over-
estimate DVT), and two thirds of the detected cases were
below the knee. In fact only 6 patients of the eighteen DVT
cases had proximal extension confirmed by venography
(which makes the incidence of DVT 6.6% if below knee cases
are excluded).
Similarly Olin JW et al.15 reported another high DVT inci-
dence of 18% on a small sample of fifty aortic patients
detected by venography. Despite the fact that 78% of the
detected DVTs were in the calf, they recommended treat-
ment of those cases, and serial Doppler follow up if antico-
agulants are contra-indicated. They supported theirrecommendation by Philbrick and Becker16 review that
suggests a calculated risk of pulmonary embolism in calf DVT
to be 10%. But this was a general calculated risk including all-
cause DVT that is not specific to surgical or vascular patients.
In addition, Philbrick and Becker clearly stated that data
concerning untreated patientswere particularly scarce. Their
no-treatment group included five studies which were classi-
fied according to the authors [ninemethodological standards]
into three methodologically weak (Bauer 1942, Hull 1981,
Moser and LeMoine 1981)17e19and two moderately strong
studies (Kakkar 1969 and Doouss 1976) and neither of those
studies documented their criteria to diagnose PE. And even in
the major point of concern (calf DVT proximal propagation)
the two moderately strong studies varied significantly as
Kakkar VV (nZ 39) reported a propagation rate of 23% while
Doouss TW (nZ 124) reported proximal propagation in only
5.6% of calf DVTs.
Consequently, other studies continued to consider calf
DVT as clinically insignificant, supporting their argument by
further evidence from other randomised controlled trials in
other specialties.20
DVT in EVAR
Eagleton et al.11 studied fifty cases of EVAR (three of them
done as emergency) and reported a DVT incidence of 6%
only. However, the diagnosed DVT cases were actually
a very high risk group as one of them had intra-operative
femoral vein injury, and the other was on chemotherapy for
lung cancer. Therefore they couldn’t provide enough
evidence to justify DVT screening or prophylaxis in this
group. It’s worth mentioning here that 18% of the patients
were already on warfarin and 56% were on Aspirin which
were not stopped preoperatively.
DVT in general arterial operations
In the RCT group only Spebar et al.9 study compared anti-
coagulants (heparin) to control in 43 vascular patients and
reported DVT incidence of 10.5% in the control group and
12.5% in the heparin group, with no significant difference
between the two. Diagnosis was made using Fibrinogen
uptake test. However, venography confirmed only one case
(which was an aortic case on prophylaxis that progressed to
PE making the incidence of confirmed DVT in this study 2.3
percent. Nevertheless, the sample size was too small to
generalise results).
The second randomised study by Harjola P. et al.21 on
400 cases compared the use of Acetylsalicylic acid and
Dipyridamole to control in patients undergoing peripheral
vascular reconstructive surgery. They reported a DVT inci-
dence of 7.2% in control group and 3.3% in the combined
anti-platelets treatment group. Two of the DVT cases in the
control group progressed to fatal PE, but there was no
details about the operation they had, or the risk factors
related to those cases specifically. Unfortunately the
diagnosis of DVT was only on clinical suspicion confirmed by
venogram.
The third randomised trial by Urbanyi B22 compared the
use of heparin, heparin-dihydroergotamine or dextran-60 in
vascular surgery in general with no control group. Almost one
Table 1 A table of studies Included in the review
Study type No. of
Pts.
Procedures DVT incidence PE
incidence
Anti-coag. use Dx. Tool PE
Mortality
conclusion
Aortic Cases
Angelides MS
(1977)
Prospective 88 AAA:68, others:18 20.50% none none Fibrinogen uptake
test(FUT)
none Aortic surgery patients
should have DVT prophylaxis
Belch JF (1979) RCT 49 Aortic bifurcation
graft
24% control,
8% LMWH
none 50%LMWH 50%
Saline
FUT scan twice then
venogram
6.1% (3
cases)
Significant incidence of DVT,
but conventional anti-coag
is inappropriate
Satiani B (1979) Prospective 22 9 AAA, 13 Aorto
femoral
0% none none FUTþ Plethesmography
confirmed by venogram
none Impending Plethesmography
is recommended for DVT
evaluation in Aortic surgery
Satiani B (1980) Prospective 69 AAA, 1 aorto femoral 0% none none FUTþ Plethesmography
confirmed by venogram
none DVT is rare in Aortic surgery-
no need for prophylaxis
Reily MK (1982) Prospective 100 Aorto iliac surgery 13% 1% none FUTþ Doppler U/S
confirmed by Venogram
none Results do not support
prophylactic caval
interruption
Byrne B (1984) prospective 28 AAA repair, Aorto
bifemoral grafts
7.10% none none Fibrinogen uptake
test(FUT)
none single dose intra-operative
heparin protects surgical pts
against DVT
Speziale E (1988) RCT 92 AAA repair, Aorto
femoral bypass
6.5% LMWH,
8.6% UFH
none 50% on LMWH,
50% on UFH
FUT confirmed by
Doppler
none LMWH is effective & well
tolerated
Olin JW (1993) Prospective 50 Aortio bifemoral, bi-
iliac, interposition
graft
18% none None Venogram on 5th post
op. day
none treat below knee DVT,
&serial Doppler F/U if
anticoagulants are contra-
indicated
Killewich LA (1997) RCT 98 Aortic reconstructive
surgery
2% 1% in
control
UFHþ calf
compression
Vs control
Duplex U/S at 1, 3,
7days post op.
none incidence is low,
agggressive intervention did
not change the outcome
Eagleton MJ (2002) Prospective 50 EVAR 6% none None (18%
already on
warfarin)
Duplex U/S 1st day
post op &4wks later
none the 3 DVT cases were v.high
risk(DVT screening and
prophylaxis not justified)
General Vascular
Harjola PT (1980) RCT 400 Reconstructive
Arterial surgery
7.2% control,
3.3% cobined
antipaltelets
0.50% Dipyridamole,
Acetylsalicylic
Acid
Venogram on clinical
suspecion
0.50% Dipyridamole &
Acetylsalicylic acid have
synergistic anti-thrombotic
effect
Spebar MJ (1981) RCT 43 AAA, Carotids,
sympathectomy,LL
procedures.
12.5% UFH,
10.5% in
control
2.3% (on
heparin)
Heparin FUT confirmed by
venogram
none Peroperative heparin
prophylaxis is unnecessary
Urbanyi B (1982) RCT 130 Carotids, Aortic and
others
2.4% UFH or
UFH-dihydergot,
6.4% on
Dextran-60
none Heparin or
heparin-
dihydergot,
Dextran-60
FUT confirmed by
venogram
none All interventions are equally
effective in preventing DVT
after arterial surgery
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Gossetti B (1988) Prospective 40 25 Aorto femoral, 8
fem-pop, 7 extra
anatomical
2.50% none LMWH FUT, Doppler U/S none LMWH effective &safe in
preventing DVT in high risk
arterial surgery
Farakas JC (1993) Prospective 233 Aortic, fem-distal 7.5%, 3.7% none Heparin,
Enoxapirin
Duplex confirmed by
venogram
None Enoxapirin is safe&effective
Fletcher JP (1997) Prospective 142 Aortic, fem-distal,
amputations, others
7.7% aortic
cases
none UFH,
compression
devices
Duplex ultrasound
only
None moderate risk of DVT
despite standard
prophylaxis
Hollyoak M (2001) Prospective 50 22 AAA repair, 28 LL
procedures
41% in AAA,
18% in LL
one case
2%
none Color flow Duplex one
(excluded)
High incidence but small
sample
Infra-inguinal
Myhre HO (1974) Prospective 25 Fem pop: 24,
Aortoiliac:1
8% none Dextran 2days,
then warfarin
venogram no low incidence of DVT as a
cause of LL oedema after LL
arterial surgery
Passman MA (2000) Prospective 71 infra-inguinal re-
vascularization
2.80% none no routine
prophylaxis
Duplex U/S none routine prophylaxis is not
recommended except for
specific indication
Morrison ND (1976) prospective 66þ 369 Fem pop bypass
grafting
8% NA Dextran Venogram NA Dextran is effective
anticoag. Measure that does
not affect morbidity
Amputations
Barnes RW (1976) Prospective 35þ 52 Below/above knee
amputation
none 1 pt none Doppler U/S none Prophylaxis is unneccessary
in Amputations
Yeuger RA (1995) Prospective 72 below knee:31,
above knee: 41
12.50% none not routinely
(14% were on
warfarin)
Duplex no DVT prophylaxis is not
recommended
Burke B (2000) Prospective 8 below knee
amputation
50% none none Doppler U/S
at2&4 wks
no high incidence of DVT, long
F/U needed
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570 M. Bani-Hani et al.third of the 130 cases in this study were carotid endarterec-
tomy cases. They reported a DVT incidence of 2.4% in the
heparin and combination group and 6.4% in the dextran group.
Notably, out of the ten DVTcases diagnosed by FUT four cases
only were confirmed by a positive venogram.
The fourth randomised study by Farakas et al.23 repor-
ted a DVT incidence of 3.4% on heparin/LMWH prophylaxis,
unfortunately there was no control (no-treatment) group.
The reported DVT incidence in the other three
prospective non-randomized studies varied hugely between
2.5% and 41%. Gossetti et al.24 reported a DVT incidence of
2.5% (nZ 40) with LMWH prophylaxis. However, all those
fibrinogen uptake test detected cases were proven negative
by Duplex ultrasound scan. While Fletcher et al.12 reported
a DVT incidence of 9.1% (nZ 121) using heparin prophylaxis
. Diagnosis was made using Duplex ultrasound only. On the
other hand Hollyoaks et al.25 reported an exceptionally
high incidence of DVT (41%)detected by colour Doppler scan
on a small sample of fifty vascular patients (22 aortic
procedures) using no prophylaxis. The authors concluded
that the results could not be generalised because of the
small number of cases included. Furthermore, this partic-
ular group of patients had a higher mortality rate and
a higher complications rate than the usual for the authors
own practice. Notably 80% of the detected DVT cases were
in the calf veins (if excluded incidence becomes 8.2%).
Infra-inguinal reconstructive surgery
Two studies dealt exclusively with infra-inguinal proce-
dures. Both were prospective non randomized trials. The
first study by Passman et al.26 used no prophylaxis and
reported a DVT incidence of 2.8% in 71 cases using Doppler
scan. While Morrison et al.27 used Dextran prophylaxis, and
reported a DVT incidence of (8%) diagnosed by venography.
Yet again the available contradicting evidence is not
enough to judge the use of anticoagulants in DVT prophy-
laxis after arterial reconstructive surgery.
As a general rule earlier studies used no DVT prophylaxis
and did not demonstrate a significant advantage of using
anticoagulants. However, the small size of the samples and
design of the studies limits the value of their conclusions.
On the other hand and under the influence of strong
evidence from general and orthopaedic surgery more
recent studies found it difficult to justify not using antico-
agulants in their protocols and passed their results under
the umbrella of DVT in general surgery without having a real
(no-treatment) control. Although ethically sound, such
approach may not reflect the actual incidence of DVT in
vascular surgery and totally ignores the risk of bleeding in
this specialty.6
Other than the small size samples in the majority of
these studies, there seemed to be two major points of
controversy that need to be clarified before addressing the
main question of DVT prophylaxis in arterial surgery. Firstly,
the variation in screening tools used and secondly the
importance of below knee DVT. Earlier studies used fibrin-
ogen uptake test which significantly overestimated DVT
incidence while venography was too invasive to apply in
large scale studies. However the advances in ultrasound
Doppler tools made it the preferred screening tool in later
studies. Unfortunately Doppler studies are not sensitive indetecting calf DVT which forced the authors to decide
before hand about the significance of calf DVT choosing
from the available evidence which is quite controversial. In
figures, the calculated incidence of DVT in arterial surgery
would drop from 12% to 6% in aortic cases and 4% in other
peripheral re-constructive surgeries if calf DVT is consid-
ered non-significant!
DVT in vascular amputations
The three prospective studies looking at DVT in amputations
reported a variable incidence between (0e50percent).
Additional 21 caseswere studied as a part of general vascular
operations in Fletcher study with DVT incidence of 14.3%.12
We excluded Burke et al. study28 which reported the
highest incidence of DVT (50%) on a very small sample of
eight below knee amputations. Authors attributed their
high result to the use of protective cast in rehabilitation.
Nevertheless, the authors admit that they could not
exclude pre-operative DVT. Furthermore, three of the four
DVT cases were found to have protein S deficiency, one of
them combined with protein C deficiency.
Yeager et al.29 studied 72 amputations (31 above-knee
and 41 below-knee) using no prophylaxis, reporting a DVT
incidence of 12.5%. However, six of the diagnosed nine DVT
cases were picked up pre-operatively, and only three cases
(4.1%) post operatively using Duplex scan. The authors
concluded that the operative procedure itself may play
a minor role in the pathogenesis of DVT associated with
lower extremity amputations, recommending regular peri-
operative duplex scanning for DVT rather than prophylaxis.
They also recommended further prospective evaluation of
their approach.
The main drawback on this study is that 14% of the
patients were actually on warfarin. In addition, the
patients were followed up only during hospitalisation with
no further follow up in the rehabilitation period.
The other study by Barnes et al.30 included only 35 cases
enrolled prospectively while the rest of the 87 included
cases were considered retrospectively. They reported no
cases of DVT in vascular amputee. However, they reported
one case of confirmed PE three weeks post operatively
after the patient’s fall on the stump. Duplex scan was used
for screening.
In Fletcher et al. study the 21 amputation cases had
a high incidence of DVT (14%) despite being on heparin
prophylaxis. DVT diagnosed by Duplex ultrasound scanning.
Unfortunately there was no control group to quantify the
benefit of heparin in this case, especially that this group
also had the highest rate of morbidity (33%) and mortality
(23.8%).
In conclusion, the existing pre-operative risk of DVT in
vascular amputation patients does not seem to be affected
much by the procedure, and further studies are needed
before deciding to adopt prophylactic measures in this group.
Pulmonary embolism (PE)
The significance of DVT comes from its most feared compli-
cation of pulmonary embolism, and the high mortality
related to it. In a retrospective study Korwin et al.311979
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incidence of PE after aortic surgery (with 29% mortality) and
recommended vena-caval filter for aortic patients.
However, those results were not reproduced by any later
study. Practically therewas no confirmedmortality due to PE
in aortic surgery patients regardless of the prophylactic
method. And excluding the Korwin study, pulmonary embo-
lismwas reported in four aortic cases only, one was clinically
suspected PE mortality but post mortem exam was not per-
formed25 while the other three cases were non fatal, one of
them confirmed by V/Q scan,32 another was on heparin
prophylaxis,9 and the last was a high risk patient with
complicated prolonged post operative recovery.10
On the other hand there was only three documented
cases of PE in all the other vascular cases21,33 with two
mortalities, but unfortunately we do not have further
information about them. Thus the total number of reported
cases of PE in vascular patients is seven (0.4%), with two
mortalities (0.1%) out of a total number of 1848 cases in this
review. In accordance with the previous review by Satiani
et al.34 which reported the incidence of PE in aortic
patients to be less than 0.7%, and fatal PE to be as rare as
0.2%. Notably the joint vascular research group also
reported a low incidence of PE (0.014) after aortic
aneurysm surgery.35
Major bleeding
Interestingly, the only randomised trial that recommended
prophylaxis did not support the use of anti-coagulants in
vascular patients because of high rate of hemorrhagic
complications. However this high rate was not reported in
any of the other studies despite the use of similar antico-
agulant regimens. Farakas et al.23 reported the incidence
of major haemorrhage to be 2.7% and Fletcher et al.12
reported an incidence of 2.5% while all the other studies did
not report any clinically significant bleeding.
Variation of DVT incidence and screening methods
The clinical diagnosis of DVT is often masked by post
operative limb swelling and hyperaemia of reperfusion,
a fact that significantly contributes to the problem of ‘‘over
diagnosing’’ DVT which is well recognised in fibrinogen
uptake test (FUT). Fibrinogen uptake test is reported to
have accuracy of 90e94% but fails to detect higher iliac
thrombi, and recognised to have a false positivity between
20e30% of the cases. In the Satiani et al. study in 1979 none
of the ten cases detected by FUT proved to be positive, and
in his later study only three of the 16 positive cases were
confirmed by venography. Similarly, all cases detected by
FUT in Spebar et al. study proved to be negative by
venography except a single obvious case above knee DVT.
Reily et al. compared FUT and Doppler ultrasonography to
gold standard (venography) and reported a false positivity
rate of 31% and 20% respectively. Finally, as would be
expected, studies that relied on clinical detection of DVT
reported the lowest incidence.8
In 1977 Angelides et al.14 reported a DVT incidence of
20.5% if no prophylaxis was used. They relied totally on FUT
scan. Two years later in 1979 Belch et al.6 tried to reducethat incidence using heparin prophylaxis, and although they
confirmed a similar incidence of 24% in the no-treatment
group using FUT this study was terminated at an early stage
because of the high rate of major bleeding and mortality
related to anti coagulant use. In the same year Satiani
et al.36 tried to improve the sensitivity of DVT detection by
adding impendence plethesmography to FUT but his find-
ings doubted the earlier reports blaming the high false
positivity of FUT for the results and reporting no evidence
of DVT in aortic surgery on a small sample of 22 patients.
Later in 1980 Satiani34further confirmed his findings on
a larger series of 69 patients (138 limbs) reporting an inci-
dence 1.4% on no prophylaxis. Along the same lines Harjola
et al. reported a DVT incidence of 7.2% in vascular patients
on no prophylaxis using venography as diagnostic tool.
In 1982 Reily32further confirmed the unacceptably high
false positivity associated with FUT as he combined it with
Doppler ultrasound and venographic confirmation. He
reported a statistically insignificant DVT incidence of 13%
(on no prophylaxis) in100 patients who underwent aorto-
iliac surgery with no prophylaxis. Nevertheless, Byrne
et al.33 used FUT again in 1984 (nZ 28) and reported DVT
incidence of 7.1% recommending no prophylaxis. Interest-
ingly, Speziale13 reported a similar DVT incidence of 7.5%
in heparinised patients as he compared UFH to LMWH in
aortic patients using the combination of FUT and Doppler
ultrasound. Urbanyi B et al. reported a DVT incidence of
2.4% on heparin and 6.4% on dextran with no siginificant
difference between the two using FUT and venographic
confirmation.
In 1993 Olin JW15 attempted to clarify the picture using
direct venographic diagnosis on the 5th post operative day
and reported a DVT incidence of 18%. However 78% of those
were calf DVTs which were considered significant depending
on Philbrick and Becker review.16 As the latter did not have
enough data in the surgical settings and did not provide
strong evidence particularly in the no-treatment group;
others like Killewich et al.10still believed that calf DVT is not
significant. So in 1997 they excluded calf DVT and reported
an incidence of 2% in aortic reconstructive surgery regardless
of the prophylactic measure used. This time colour flow
duplex was used as a diagnostic tool.
In general the use of venography was kept for confir-
matory stage while the screening methods varied widely,
and with time there was an increasing trend towards using
Duplex scans for screening purposes, adding the new
advances in colour Doppler techniques made it the ideal
screening tool for a large scale study that is needed to clear
all the controversy surrounding DVT in vascular field.
Ideally the answer to the DVT argument in arterial
surgery should be tackled by a large-scale (possibly multi-
centre) randomised controlled trial. However, there will be
a few hurdles to such approach. Firstly, the ethical
dilemma of depriving high-risk patients from anticoagulant
prophylaxis and subsequently finding the best control
group. Secondly, in the age where endovascular interven-
tion has replaced many open procedures, it might be
difficult to find enough surgeons willing to take part in such
a study. Thirdly, as demonstrated in this review other
points of controversy need to be addressed prior to
designing such study including: the significance of below
knee DVT, the best screening tool, incidence and relevance
572 M. Bani-Hani et al.of sub-clinical PE, ideal prophylactic measures, and safety
of anti-coagulants in arterial surgery. In addition, the
higher-risk patients with prolonged recovery and added co-
morbidities may need to be addressed in a separate arm of
the study for obvious reasons.
Conclusion
Collectively the available evidence is insufficient to make
a valid conclusion regarding the use of anticoagulant
prophylaxis in arterial surgery.
Despite the controversy surrounding DVT in arterial
surgery, there seems to be one favourable point of agree-
ment between all the studies, which is the small incidence
of pulmonary embolism, as well as the rare mortality
related to it (only two confirmed cases, and one sus-
pected). Although this finding suggests a genuine protective
effect of intra operative heparin, it may also reflect
a major failure in study designs to precisely define the
extent of this phenomenon.
Until all these questions are answered DVT prophylaxis
in vascular patients will continue to be guided by evidence
of prophylaxis gained from studies of general surgical
patients.
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